Abstract: An oral or topical composition having tanning and sun-screening activity, and the cosmetic uses thereof, are disclosed. The composition regulates skin pigmentation and includes carotenoids. Said composition essentially contains a component (a) consisting of at least one natural carotenoid having provitamin A activity, and selected from the group which consists of .beta.-carotene and/or .alpha.-carotene, and a component (b) corresponding to at least one natural carotenoid having no provitamin A activity, and consisting of lycopene, optionally in combination with a further component (b) selected from the group which consists of zeaxanthine, cryptoxanthine and lutein or a mixture thereof. The ratio of components (a) to lycopene is from 0.95:1 to 1:50.

Abstract: The adherent coating of the invention comprises a stabilizing polymer together with an active agent (a hydrophilic polymer and/or a bioactive agent) in a layer bonded to the surface of a medical device. This invention encompasses the coating liquids used for coating medical devices, methods of coating the devices, and the coated devices. The stabilizing polymer is selected to entrap the active agent in a coating that has a high degree of flexibility and has improved bonding to a wide variety of substrates. Preferred stabilizing polymers are cross-linkable acrylic and methacrylic polymers, ethylene acrylic acid copolymers, styrene acrylic copolymers, vinyl acetate polymers and copolymers, vinyl acetal polymers and copolymers, epoxy, melamine, other amino resins, phenolic polymers, copolymers thereof, and combinations.

Abstract: A shaped crystalline deodorant is made from mixture of a mineral salt and water which is heated above the melting point of the salt, placed in a mold having the desired shape, and crystalized after insertion of an internally threaded member into the mixture. The deodorant has an oval cross-sectional shape with the insert imbedded therewithin and is secured into a container. The container includes a threaded stem attached to the container for rotational movement which is translated to axial movement of the deodorant with respect to the container. The threaded stem cooperates with the internally threaded insert to allow the crystallized deodorant to be moved up or down within the container by rotating the threaded stem.

Abstract: A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of:(a) a pellet comprising an inert core component, a therapeutically effective amount of omeprazole, a surface active agent, a filler, a pharmaceutically acceptable alkaline agent and a binder; and(b) a single layer of coating on said pellet which comprises a layer of an enteric coating agent.

Abstract: The present invention relates to compositions for preventing or treating skin disorders using flavonoid compounds. The present invention also relates to methods for regulating skin condition.

Abstract: The invention relates to a photostable screening cosmetic composition for protecting human skin against UV rays, comprising, comprising avobenzone, octyl-methoxycinnamate, and an additional constituent, R, where R is selected from the group consisting of titanium dioxide and zinc oxide.

Abstract: An aqueous liquid detergent composition is substantially transparent in the absence of opacifier contains a sunscreen together less than 5 wt. % of detergency builder and/or comprises a water-miscible polar organic solvent. The solvent and fluorescer or ultraviolet absorbing agent are mixed together as a premix prior to incorporation in the composition as a whole.

Abstract: A method of forming a multi-layer polyester preform and container, particularly suitable for refillable PET carbonated beverage bottles, having an interior layer of high copolymer polyester material which resists hazing in the preform injection stage, and at least one exterior layer of a polyester to achieve enhanced strain-induced crystallization in the exterior layer during blow molding. The container can withstand higher caustic wash temperatures and exhibits reduced flavor carryover from one product to another.

Abstract: Optically pure S(+) flurbiprofen, which is substantially free of the R(-) enantiomer, is a potent analgesic for relieving pain and inflammation in humans and animals. A method and composition is disclosed utilizing the optically pure S(+) enantiomer of flurbiprofen for treating pain and inflammation.

Abstract: Varying the daily dose of either or both of the estrogen and the progestogen administered for hormone replacement therapy (HRT) is readily and inexpensively accomplished, without the necessity of the physician prescribing a new product each time the daily dose of the estrogen or progestogen is changed, by administering preferably transdermally the estrogen and the progestogen contained in separate extrudable pharmaceutical compositions from a dispenser which contains means, preferably adjustable only by the attending physician or dispensing pharmacist, for varying the volume of either or both of the respective compositions which is dispensed as a single dose from the dispenser in response to a defined digital dispensing manipulation of the dispenser thereby facilitating optimal compliance to a combination of HRT with individually adjusted dosages of the estrogen and progestogen.

Abstract: A filled structure characterized by the combination of high compressive and tensile strength to allow a high bending load includes a fiber reinforced resinous hollow structure having a tensile strength of at least 30,000 psi. The hollow structure has first and second ends, an inside surface forming a boundary which encloses a space, and an outside surface. At least a portion of the outside surface of one of the ends has a roughened portion sufficient to provide frictional resistance with the ground when the one end is driven into the ground. A hard core is disposed within the space enclosed by the hollow structure. The hard core has a density of at least 35 pounds per cubic foot and a compressive strength of at least 1500 psi. The hard core is formed from a mixture of particulate cementitious material and liquid.

Abstract: A blow molded hollow doubled wall article wherein the inner wall has an edge portion and a central portion adjacent the edge portion, including at least one opening in the central portion providing access to the space between the inner and outer walls and forming a flap member connected to said edge portion.

Abstract: A viscous gel for delivering minor effective homeopathic amount of zinc or another metal to the nasal membrane.

Abstract: Pressure sensitive adhesive compositions for use in transdermal drug delivery systems comprising an adhesive composition which is tolerant to plasticization by cutaneous penetration enhancers contained in the transdermal drug formulation are disclosed. Specifically, the pressure sensitive adhesive composition of the present invention comprises an acrylic copolymer prepared from (i) at least 40% by weight of th total monomer composition of alkyl acrylate monomers with a Tg of -90 to 0.degree. C., (ii) 0-15% by weight of the total monomer composition of monomers with a Tg of 0 to 250.degree. C., and (iii) 10-60% by weight of the total monomer composition of substituted acrylamides or methacrylamides having the structural formula: ##STR1## wherein R.sub.1 is H or CH.sub.3,R.sub.2 is H or CH.sub.3, andR.sub.3 is (a) CH.sub.3,(b) C(CH.sub.3).sub.2 --(CH.sub.2).sub.n --CH.sub.3 where n is 0 through 17, or(c) substituents of the formula: ##STR2## where m is 0 through 10, and optionally(iv) at least 0.

Abstract: A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of:(a) a pellet comprising an inert core component, a therapeutically effective amount of omeprazole, a surface active agent, a filler, a pharmaceutically acceptable alkaline agent and a binder; and(b) a single layer of coating on said pellet which comprises a layer of an enteric coating agent.

Abstract: The present invention relates to methods of making enhanced efficacy antiperspirant salts and particularly stabilized aqueous polyhydric alcohol solutions of such salts. One such method involves stabilizing an aqueous solution of an enhanced efficacy antiperspirant salt by adding an effective amount of a polyhydric alcohol having from 3 to 6 carbon atoms and from 3 to 6 hydroxyl groups. A second disclosed method involves preparing an enhanced efficacy aluminum antiperspirant salt by heating an aqueous solution of an aluminum antiperspirant salt in the presence of a polyhydric alcohol having from 3 to 6 carbon atoms and from 3 to 6 hydroxyl groups at a temperature of at least 50.degree. C. for a time sufficient to convert the salt to an enhanced salt.

Abstract: An oil-in-water emulsified composition comprising an a .alpha.-monoalkyl glyceryl ether, a wax, and a silicone oil: wherein the amount of the silicone oil is not less than 10 wt % with respect to an oil phase except the a .alpha.-monoalkyl glyceryl ether and the wax, this composition displays excellent emulsion stability and feeling of use.

Abstract: The present invention relates to cosmetic products having a whitening effect, which comprises mulberrin.According to the present invention, an aqueous suspension of the Ramulus mori extract, which have been obtained by extracting young branches of plants belonged to Morus genus with water or an organic solvent, is fractionated by organic solvents, isolated and purified to give mulberrin, which is then added to conventional skin-care cosmetics to give whitening cosmetics having an excellent whitening effect.

Abstract: An exogenous stimulus is applied to tissues or cells which are at risk in a subsequent surgical procedure or other intervention which induces a response by the cells that minimizes reaction to the subsequent procedure. Stimuli can be chemical, physiological or physical. Examples include those stimuli known to induce expression of stress response proteins or heat shock proteins, especially heat shock protein 70 (hsp 70) and hsp 90, for example, exposure to heat or dilute hydrogen peroxide, or direct administration of exogenous heat shock proteins, or those stimuli which act to inhibit or reduce heat shock protein expression, for example, treatment with flavonoids.

Abstract: Preventive as well as therapeutic treatment to alleviate cosmetic conditions and symptoms of dermatologic disorders with amphoteric compositions containing alpha hydroxyacids, alpha ketoacids, related compounds or polymeric forms of hydroxyacids is disclosed. The cosmetic conditions and the dermatologic disorders in which the amphoteric compositions and the polymeric compounds may be useful include dry skin, dandruff, acne, keratoses, psoriasis, eczema, pruritus, age spots, lentigines, melasmas, wrinkles, warts, blemished skin, hyperpigmented skin, kyperkeratotic skin, inflammatory dermatoses, skin changes associated with aging, and skin requiring cleansers.